Multidrug-Resistant Proteus mirabilis Strain with Cointegrate Plasmid

Microorganisms
Andrey ShelenkovVasiliy Akimkin

Abstract

Proteus mirabilis is a component of the normal intestinal microflora of humans and animals, but can cause urinary tract infections and even sepsis in hospital settings. In recent years, the number of multidrug-resistant P. mirabilis isolates, including the ones producing extended-spectrum β-lactamases (ESBLs), is increasing worldwide. However, the number of investigations dedicated to this species, especially, whole-genome sequencing, is much lower in comparison to the members of the ESKAPE pathogens group. This study presents a detailed analysis of clinical multidrug-resistant ESBL-producing P. mirabilis isolate using short- and long-read whole-genome sequencing, which allowed us to reveal possible horizontal gene transfer between Klebsiella pneumoniae and P. mirabilis plasmids and to locate the CRISPR-Cas system in the genome together with its probable phage targets, as well as multiple virulence genes. We believe that the data presented will contribute to the understanding of antibiotic resistance acquisition and virulence mechanisms for this important pathogen.

References

Aug 24, 2007·FEMS Immunology and Medical Microbiology·Sérgio P D RochaJacinta S Pelayo
Dec 25, 2007·Gene·Andrew ShelenkovEugene Korotkov
Apr 28, 2009·Computational Biology and Chemistry·Andrew Shelenkov, Eugene Korotkov
May 26, 2010·FEMS Microbiology Reviews·Randy M MorgensteinPhilip N Rather
Mar 12, 2011·The Journal of Antimicrobial Chemotherapy·Jannine K BaileyRuth M Hall
Aug 24, 2011·Revista Da Sociedade Brasileira De Medicina Tropical·Afonso Gomes AbreuAzizedite Guedes Gonçalves
Jul 12, 2012·The Journal of Antimicrobial Chemotherapy·Ea ZankariMette Voldby Larsen
Mar 16, 2013·RNA Biology·Ambarish BiswasChris M Brown
Apr 6, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sen ZhangYa-Hong Liu
Jul 19, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Debdutta BhattacharyaAttayur Purushothaman Sugunan
Jul 26, 2013·Current Microbiology·Silvia Emanoele CestariJacinta Sanchez Pelayo
Mar 20, 2014·Bioinformatics·Torsten Seemann
Apr 30, 2014·Antimicrobial Agents and Chemotherapy·Alessandra CarattoliHenrik Hasman
Mar 11, 2015·Antimicrobial Agents and Chemotherapy·Kalyan D ChavdaBarry N Kreiswirth
Jul 23, 2015·Bioinformatics·Andrew J PageJulian Parkhill
Nov 7, 2015·Microbiology Spectrum·Jessica N Schaffer, Melanie M Pearson
Nov 19, 2015·Nucleic Acids Research·Lihong ChenQi Jin
Feb 13, 2016·New Microbes and New Infections·M Mac AogáinB Crowley
Apr 5, 2016·Proceedings of the National Academy of Sciences of the United States of America·Jessica N SchafferMelanie M Pearson
Oct 30, 2016·Nucleic Acids Research·Baofeng JiaAndrew G McArthur
Jun 9, 2017·PLoS Computational Biology·Ryan R WickKathryn E Holt
Jan 10, 2018·Antimicrobial Agents and Chemotherapy·Stefanie DesmetErik Bathoorn
Feb 10, 2018·EcoSal Plus·Chelsie E ArmbrusterMelanie M Pearson
Mar 25, 2018·Diagnostic Microbiology and Infectious Disease·Thomas ValentinGernot Zarfel
May 4, 2018·Archives of Virology·V MorozovaN Tikunova
Jun 11, 2018·International Journal of Biological Macromolecules·Nikolay P ArbatskyYuriy A Knirel
Jul 31, 2019·The Journal of Antimicrobial Chemotherapy·Dandan HeGongzheng Hu

❮ Previous
Next ❯

Datasets Mentioned

BETA
PRJNA645205
CP059056
CP059057
CP059058

Software Mentioned

ResFinder
BLAST
RAxML
CRISPRTarget
pMLST
Guppy
ESKAPE
Prokka
Mob
MinKNOW

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Related Papers

Cahiers R. M. F. : bulletin médical-guide du praticien-revue médicale française
RENE-MARTIN de PRAINGY
Journal of General Microbiology
A J Van Rensburg
© 2021 Meta ULC. All rights reserved